LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Withaferin A | 0.37 | uM | LJP6 | 1 | G16 | 72 | hr | 1334 | 3254 | 3955 | 0.8226 | 0.7657 |
BT-20 | Withaferin A | 0.37 | uM | LJP6 | 2 | G16 | 72 | hr | 1334 | 3420 | 3899 | 0.8771 | 0.8374 |
BT-20 | Withaferin A | 0.37 | uM | LJP6 | 3 | G16 | 72 | hr | 1334 | 3704 | 3921 | 0.9446 | 0.9280 |
BT-20 | Withaferin A | 0.37 | uM | LJP5 | 1 | G16 | 72 | hr | 1334 | 2796 | 3930 | 0.7113 | 0.6073 |
BT-20 | Withaferin A | 0.37 | uM | LJP5 | 2 | G16 | 72 | hr | 1334 | 3098 | 4051 | 0.7647 | 0.6916 |
BT-20 | Withaferin A | 0.37 | uM | LJP5 | 3 | G16 | 72 | hr | 1334 | 2879 | 4117 | 0.6992 | 0.6048 |
BT-20 | Withaferin A | 1.11 | uM | LJP6 | 1 | G15 | 72 | hr | 1334 | 1450 | 3955 | 0.3666 | 0.0543 |
BT-20 | Withaferin A | 1.11 | uM | LJP6 | 2 | G15 | 72 | hr | 1334 | 1266 | 3899 | 0.3247 | -0.0336 |
BT-20 | Withaferin A | 1.11 | uM | LJP6 | 3 | G15 | 72 | hr | 1334 | 1764 | 3921 | 0.4498 | 0.1965 |
BT-20 | Withaferin A | 1.11 | uM | LJP5 | 1 | G15 | 72 | hr | 1334 | 769 | 3930 | 0.1956 | -0.2980 |
BT-20 | Withaferin A | 1.11 | uM | LJP5 | 2 | G15 | 72 | hr | 1334 | 698 | 4051 | 0.1723 | -0.3328 |
BT-20 | Withaferin A | 1.11 | uM | LJP5 | 3 | G15 | 72 | hr | 1334 | 659 | 4117 | 0.1600 | -0.3522 |
BT-20 | Withaferin A | 3.33 | uM | LJP6 | 1 | G14 | 72 | hr | 1334 | 544 | 3955 | 0.1375 | -0.4359 |
BT-20 | Withaferin A | 3.33 | uM | LJP6 | 2 | G14 | 72 | hr | 1334 | 460 | 3899 | 0.1180 | -0.4978 |
BT-20 | Withaferin A | 3.33 | uM | LJP6 | 3 | G14 | 72 | hr | 1334 | 510 | 3921 | 0.1301 | -0.4614 |
BT-20 | Withaferin A | 3.33 | uM | LJP5 | 1 | G14 | 72 | hr | 1334 | 648 | 3930 | 0.1649 | -0.3710 |
BT-20 | Withaferin A | 3.33 | uM | LJP5 | 2 | G14 | 72 | hr | 1334 | 638 | 4051 | 0.1575 | -0.3692 |
BT-20 | Withaferin A | 3.33 | uM | LJP5 | 3 | G14 | 72 | hr | 1334 | 655 | 4117 | 0.1591 | -0.3546 |
BT-20 | Withaferin A | 10 | uM | LJP6 | 1 | G13 | 72 | hr | 1334 | 920 | 3955 | 0.2326 | -0.2113 |
BT-20 | Withaferin A | 10 | uM | LJP6 | 2 | G13 | 72 | hr | 1334 | 771 | 3899 | 0.1977 | -0.2987 |
BT-20 | Withaferin A | 10 | uM | LJP6 | 3 | G13 | 72 | hr | 1334 | 622 | 3921 | 0.1586 | -0.3880 |
BT-20 | Withaferin A | 10 | uM | LJP5 | 1 | G13 | 72 | hr | 1334 | 816 | 3930 | 0.2076 | -0.2708 |
BT-20 | Withaferin A | 10 | uM | LJP5 | 2 | G13 | 72 | hr | 1334 | 905 | 4051 | 0.2234 | -0.2154 |
BT-20 | Withaferin A | 10 | uM | LJP5 | 3 | G13 | 72 | hr | 1334 | 875 | 4117 | 0.2125 | -0.2288 |
BT-20 | LJP6 | 1 | A03 | 72 | hr | 1334 | 2833 | 3955 | 0.7162 | 0.6163 |